2Kwak HW, D Amico DJ. Evaluation of the retinal toxicity and pharma-cokinetics of dexamethasone after intravitreal injection[J]. Arch Oph-thalmol, 1992,110 (5) :259-266.
3Jonas JB,Akkoyun I,Budde WM,et al. Intravitreal reinjection of triam-cinolone for exudative age-related macular degeneration[J]. Arch Oph-thalmol, 2004,122 (4) :218-222.
5Young S,Iarkin G,Branley M, et al. Safety and efficacy of intravitreal triamcinolone for cystoid maculer edema in uveitisv[J]. Clin Experiment Ophthlmol,2001, 29(1) :2- 6.
二级参考文献13
1Black RL, Oglesby RB, von Sallman L, et al. Posterior subcapsular cataracts induced by corticoids in patients with rheumatoid arthritis. JAMA, 1960,174: 166-171.
2Derby L, Maier WC. Risk of cataract among users of intranasal corticosteroids. J Allergy Clin Immunol. , 2000,105: 912-916.
3Bettmann JW, Fund WE, Webster RG, et al. Cataractogenic effect of corticosteroids on animals. Am J Ophthalmol, 1967,63:841-844.
4Kivilcim M, Peyman GA, E1-Dessouky ES, et al. Retinal toxicity of triamcinolone acetonide in silicone-filled eyes. Ophthalmic Surg Lasers, 2000,31: 474-478.
5Gillies M, Simpson JM, Billson FA, et al. Safety of an intravitreal injection of triamcinolone. results from a randomized clinical trial. Arch Ophthalmol , 2004,22: 336-340.
6Mccuun BW, Bessler M, Tano Y, et al. The lack of toxicity of intravitreally administered triamcinolone acetonide. Am J Ophthalmol , 1981,91: 785-788.
7Gopal L, Bhende M, Sharma T. Vitrectomy for accidental intraocular steroid injection. Retina, 1995,15: 295-299.
8Enaida H, Sakamoto T, Ueno A, et al. Submacular deposition of triamcinolone acetonide after triamcinolone-assisted vitrectomy.Am J Ophthalmol , 2003,135:243-246.
9Hida T, Chandler D, Arena JE, et al. Experimental and clinical bservations of the intraocular toxicity of commercial corticosteroid preparations. Am J Ophthalmol, 1986,101 : 190-195.
10Yeung CK, Chan KP, Chiang SWY, et al. The toxic and stress responses of cultured human retinal pigment epithelium (ARPE19) and human glial cells (SVG) in the presence of triamcinolone. Invest Ophthalmol Vis Sci, 2003,44: 5293-5300.